Biggest changeThe Company expects that these milestones will be achieved in the first half of 2026; • Reductions in our cash annual operating expenses across all operating areas, representing a reduction of at least 20% as compared to 2023 levels vs. 2024 levels, including in the areas of Research and Development, Sales and Marketing and General and Administrative; • Right-sizing of operations across all areas of the Company, including headcount reductions and personnel hiring freezes; • Reduction in the rate of new product introductions and further leveraging of existing platforms to reduce new product development and engineering costs; • Delaying or curtailing discretionary and non-essential capital expenditures not related to near-term product and manufacturing needs, now that our waveguide manufacturing plant expansion has substantially been completed and the license fees payments under the Atomistic License have been completed; 44 Table of Contents • The expected margin contribution upon the commencement of volume manufacturing and sales of waveguides from our new waveguide manufacturing plant, particularly to OEM and ODM customers such as Quanta; • Continued pursuit of further licensing and strategic opportunities around our waveguide technologies with potential ODMs/OEMs, which would include the receipt of upfront licensing fees and on-going supply agreements; and • Reduction in our existing products’ selling prices and higher volume discount levels to turn as much of our inventory of finished products into cash and pursue external manufacturers for Vuzix non-waveguide production needs.
Biggest changeManagement’s plans to alleviate the conditions that raise doubt include raising further capital and the implementation of operational improvements and the curtailment of certain development programs, both of which the Company expects will preserve cash. Management’s plans concerning these matters and managing our liquidity include, among other things: 41 Table of Contents ● Reductions in our cash annual operating expenses across all operating areas, including in the areas of Research and Development, Sales and Marketing and General and Administrative; ● Delaying or curtailing discretionary and non-essential capital expenditures not related to near-term product and manufacturing needs and reducing other investing activities for the remainder of our 2026 and 2027 fiscal years; ● The expected margin contribution upon the commencement of volume manufacturing and sales of waveguides from our new waveguide manufacturing plant, particularly to OEM customers; and ● Continued pursuit of licensing and strategic opportunities around our waveguide technologies with potential OEMs, which would include the receipt of upfront licensing fees and on-going supply agreements.
The accounting estimate related to valuation of inventories is considered a “critical accounting estimate” because it is susceptible to changes from period-to-period due to the requirement for management to make estimates relative to each of the underlying factors, ranging from purchasing to sales, production, and after-sale support.
The accounting estimate related to the valuation of inventories is considered a “critical accounting estimate” because it is susceptible to changes from period-to-period due to the requirement for management to make estimates relative to each of the underlying factors, ranging from purchasing to sales, production, and after-sale support.
Cost of product revenues and engineering services are comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, software royalties, the depreciation for our tooling and manufacturing equipment, and amortization of software development costs related to the production of our products and rendering of engineering services.
Cost of product revenues and engineering services are comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, software royalties, the depreciation for our tooling and manufacturing equipment, and amortization of software development costs related to the production of our products and the rendering of engineering services.
Our research and development expenses consist primarily of compensation costs for personnel, including non-cash stock-based compensation expenses, third-party services, purchases of research supplies and materials, and consulting fees related to research and development.
Our research and development expenses consist primarily of compensation costs for personnel, including non-cash stock-based compensation expenses, third-party services, purchases of research supplies and materials, and consulting fees related to research and development.
The Company will need to grow its business significantly to become profitable and self-sustaining on a cash flow basis or it will be required to cut its operating costs significantly or raise new equity and/or debt capital. These historical financial factors initially raise substantial doubt about the Company’s ability to continue as a going concern.
The Company will need to grow its business significantly to become profitable and self-sustaining on a cash flow basis or it will be required to cut its operating costs significantly or raise new equity and/or debt capital. These historical financial factors initially raise doubt about the Company’s ability to continue as a going concern.
The following table reflects the components of our cost of goods sold: Year Ended % of Year Ended % of Dollar % Increase December 31, 2024 Total Sales December 31, 2023 Total Sales Change (Decrease) Product Cost of Sales $ 3,887,820 68 % $ 7,224,107 60 % $ (3,336,287) (46) % Inventory Reserve for Obsolescence 4,167,917 72 % 4,358,062 36 % (190,145) (4) % Manufacturing Overhead - Unapplied 2,119,380 37 % 1,615,172 13 % 504,208 31 % Depreciation and Amortization 734,456 13 % 886,117 7 % (151,661) (17) % Engineering Services Cost of Sales 444,653 8 % 680,411 6 % (235,758) (35) % Total Cost of Sales 11,354,226 197 % 14,763,869 122 % (3,409,643) (23) % Gross Profit (Loss) $ (5,599,670) (97) % $ (2,634,730) (22) % $ (2,964,940) 113 % For the year ended December 31, 2024, there was a gross loss from total sales of $5,599,670, or 97% of total sales as compared to a gross loss of $2,634,730, or 22% in 2023.
The following table reflects the components of our cost of sales: Year Ended % of Year Ended % of Dollar % Increase December 31, 2024 Total Sales December 31, 2023 Total Sales Change (Decrease) Product Cost of Sales $ 3,887,820 68 % $ 7,224,107 60 % $ (3,336,287) (46) % Inventory Reserve for Obsolescence 4,167,917 72 % 4,358,062 36 % (190,145) (4) % Manufacturing Overhead - Unapplied 2,119,380 37 % 1,615,172 13 % 504,208 31 % Depreciation and Amortization 734,456 13 % 886,117 7 % (151,661) (17) % Engineering Services Cost of Sales 444,653 8 % 680,411 6 % (235,758) (35) % Total Cost of Sales 11,354,226 197 % 14,763,869 122 % (3,409,643) (23) % Gross Loss $ (5,599,670) (97) % $ (2,634,730) (22) % $ (2,964,940) 113 % For the year ended December 31, 2024, there was a gross loss from total sales of $5,599,670, or 97% of total sales as compared to a gross loss of $2,634,730, or 22% in 2023.
General and administrative expenses include professional fees, investor relations (IR) costs, salaries and related stock compensation, travel costs, office and rental costs. Year Ended % of Year Ended % of Dollar % Increase December 31, 2024 Total Sales December 31, 2023 Total Sales Change (Decrease) General and Administrative Expenses $ 8,933,952 155 % $ 8,933,458 74 % $ 494 0 % Related Stock-based Compensation (non-cash) 8,296,341 144 % 9,658,727 80 % (1,362,386) (14) % Total General and Administrative $ 17,230,293 299 % $ 18,592,185 153 % $ (1,361,892) (7) % 38 Table of Contents General and administrative expenses for the year ended December 31, 2024, decreased by $1,361,892, or 7% compared to 2023.
General and administrative expenses include professional fees, investor relations (IR) costs, salaries and related stock compensation, travel costs, office and rental costs. Year Ended % of Year Ended % of Dollar % Increase December 31, 2024 Total Sales December 31, 2023 Total Sales Change (Decrease) General and Administrative Expenses $ 8,933,952 155 % $ 8,933,458 74 % $ 494 0 % Related Stock-based Compensation (non-cash) 8,296,341 144 % 9,658,727 80 % (1,362,386) (14) % Total General and Administrative $ 17,230,293 299 % $ 18,592,185 153 % $ (1,361,892) (7) % 39 Table of Contents General and administrative expenses for the year ended December 31, 2024, decreased by $1,361,892, or 7% compared to 2023.
The increase in the net dollar amount of these unapplied overhead costs in the current period versus the prior period was primarily driven by a decrease in actual production levels during the period and the temporary cessation of M400 smart glasses production in the second half of 2024. Depreciation and Amortization included in cost of sales decreased by $151,661, or 17% for the year ended December 31, 2024 versus 2023, due to the full amortization and depreciation of certain manufacturing assets. 37 Table of Contents Research and Development.
The increase in the net dollar amount of these unapplied overhead costs in the current period versus the prior period was primarily driven by a decrease in actual production levels during the period and the temporary cessation of M400 smart glasses production in the second half of 2024. Depreciation and Amortization included in cost of sales decreased by $151,661, or 17% for the year ended December 31, 2024 versus 2023, due to the full amortization and depreciation of certain manufacturing assets. 38 Table of Contents Research and Development.
A substantially greater number of holders of the Company’s common stock are in “street name” or beneficial holders whose shares are held by banks, brokers and other financial institutions. Issuer Purchases of Equity Securities We did not purchase equity securities that are registered under Section 12 of the Exchange Act during the three months ended December 31, 2024.
A substantially greater number of holders of the Company’s common stock are in “street name” or beneficial holders whose shares are held by banks, brokers and other financial institutions. Issuer Purchases of Equity Securities We did not purchase equity securities that are registered under Section 12 of the Exchange Act during the three months ended December 31, 2025.
Our wearable display products integrate micro-display technology with our advanced optics to produce compact high-resolution display engines, less than half an inch diagonally, which when viewed through our Smart Glasses products create virtual images that appear comparable in size to that of a computer monitor or a large-screen television.
Our wearable display products integrate microdisplay technology with our advanced optics to produce compact high-resolution display engines, less than half an inch diagonally, which when viewed through our Smart Glasses products create virtual images that appear comparable in size to that of a computer monitor or a large-screen television.
Impairment losses are dependent on a number of factors such as general economic trends and major technology advances, and thus could be significantly different from historical results. For the years ending December 31, 2024 and 2023, there were no indicators of impairment present.
Impairment losses are dependent on a number of factors such as general economic trends and major technology advances, and thus could be significantly different from historical results. For the years ending December 31, 2025 and 2024, there were no indicators of impairment present.
As of December 31, 2024 and 2023, deferred revenue associated with our expected returns was immaterial. The Company collects and remits sales taxes in certain jurisdictions and reports revenue net of any associated sales taxes. Revenue from engineering consulting and other services is recognized at the time the services are rendered.
As of December 31, 2025 and 2024, deferred revenue associated with our expected returns was immaterial. The Company collects and remits sales taxes in certain jurisdictions and reports revenue net of any associated sales taxes. Revenue from engineering consulting and other services is recognized at the time the services are rendered.
Going Concern For all annual and interim periods, management will assess going concern uncertainty in our consolidated financial statements to determine whether there is sufficient cash on hand and working capital, including available borrowings on loans, to operate for a period of at least one year from the date the consolidated financial statements are issued or available to be issued, which is referred to as the “look-forward period”, as defined in U.S.
Going Concern For all annual and interim periods, management assesses our going concern uncertainty in our consolidated financial statements to determine whether there is sufficient cash on hand and working capital, including available borrowings on loans, to operate for a period of at least one year from the date the consolidated financial statements are issued or available to be issued, which is referred to as the “look-forward period”, as defined in U.S.
If actual demand, market conditions or product life cycles differ from estimates, inventory adjustments to net realizable values would result in a reduction to the carrying value of inventory, an increase in inventory write-offs and a decrease to gross margins.
If actual demand, market conditions or product life cycles differ from estimates, inventory adjustments to net realizable values could result in a reduction to the carrying value of inventory, an increase in inventory write-offs and a decrease to gross margins.
The adequacy of the provision is assessed at each quarter end and is based on historical experience of warranty claims and costs. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale.
The adequacy of the provision is assessed at each quarter end and is based on historical experience and projected factors of warranty claims and costs. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale.
Recent Accounting Pronouncements Refer to Note 1 35 Table of Contents Results of Operations for Fiscal Years Ended December 31, 2024 and December 31, 2023 The following table compares the Company’s consolidated statements of operations data for the years ended December 31, 2024 and 2023. Year Ended December 31, Dollar % Increase 2024 2023 Change (Decrease) Sales: Sales of Products $ 4,487,202 $ 10,760,352 $ (6,273,150) (58) % Sales of Engineering Services 1,267,354 1,368,787 (101,433) (7) % Total Sales 5,754,556 12,129,139 (6,374,583) (53) % Cost of Sales: Cost of Sales - Products Sold 6,007,200 8,839,279 (2,832,079) (32) % Cost of Sales - Inventory Reserve for Obsolescence 4,167,917 4,358,062 (190,145) (4) % Cost of Sales - Depreciation and Amortization 734,456 886,117 (151,661) (17) % Cost of Sales - Engineering Services 444,653 680,411 (235,758) (35) % Total Cost of Sales 11,354,226 14,763,869 (3,409,643) (23) % Gross Profit (Loss) (5,599,670) (2,634,730) (2,964,940) 113 % Gross Profit (Loss) % (97) % (22) % Operating Expenses: Research and Development 9,626,452 12,339,534 (2,713,082) (22) % Selling and Marketing 8,191,427 12,711,800 (4,520,373) (36) % General and Administrative 17,230,293 18,592,185 (1,361,892) (7) % Depreciation and Amortization 2,994,643 3,844,428 (849,785) (22) % Loss on Goodwill and Other Intangible Asset Impairment — 2,136,993 (2,136,993) (100) % Loss on Fixed Asset Disposal 27,654 — 27,654 NM Impairment on Intangible Asset and Equity Investment 30,301,355 — 30,301,355 NM Impairment of Patents and Trademarks — 41,869 (41,869) (100) % Loss from Operations (73,971,494) (52,301,539) (21,669,955) 41 % Other Income (Expense): Investment Income 591,319 2,219,226 (1,627,907) (73) % Other Taxes 59,335 (230,973) 290,308 (126) % Foreign Exchange Loss (217,317) (44,062) (173,255) 393 % Utility Improvement Refund/Employee Retention Credit Refund — 208,271 (208,271) (100) % Total Other Income, Net 433,337 2,152,462 (1,719,125) (80) % Net Loss $ (73,538,157) $ (50,149,077) $ (23,389,080) 47 % 36 Table of Contents Sales.
There were no provisions for income taxes in 2025 or 2024. 36 Table of Contents Results of Operations for Fiscal Years Ended December 31, 2024 and December 31, 2023 The following table compares the Company’s consolidated statements of operations data for the years ended December 31, 2024 and 2023. Year Ended December 31, Dollar % Increase 2024 2023 Change (Decrease) Sales: Sales of Products $ 4,487,202 $ 10,760,352 $ (6,273,150) (58) % Sales of Engineering Services 1,267,354 1,368,787 (101,433) (7) % Total Sales 5,754,556 12,129,139 (6,374,583) (53) % Cost of Sales: Cost of Sales - Products Sold 6,007,200 8,839,279 (2,832,079) (32) % Cost of Sales - Inventory Reserve for Obsolescence 4,167,917 4,358,062 (190,145) (4) % Cost of Sales - Depreciation and Amortization 734,456 886,117 (151,661) (17) % Cost of Sales - Engineering Services 444,653 680,411 (235,758) (35) % Total Cost of Sales 11,354,226 14,763,869 (3,409,643) (23) % Gross Loss (5,599,670) (2,634,730) (2,964,940) 113 % Gross Loss % (97) % (22) % Operating Expenses: Research and Development 9,626,452 12,339,534 (2,713,082) (22) % Selling and Marketing 8,191,427 12,711,800 (4,520,373) (36) % General and Administrative 17,230,293 18,592,185 (1,361,892) (7) % Depreciation and Amortization 2,994,643 3,844,428 (849,785) (22) % Loss on Goodwill and Other Intangible Asset Impairment — 2,136,993 (2,136,993) (100) % Loss on Fixed Asset Disposal 27,654 — 27,654 NM Impairment on Intangible Asset and Equity Investment 30,301,355 — 30,301,355 NM Impairment of Patents and Trademarks — 41,869 (41,869) (100) % Loss from Operations (73,971,494) (52,301,539) (21,669,955) 41 % Other Income (Expense): Investment Income 591,319 2,219,226 (1,627,907) (73) % Other Taxes 59,335 (230,973) 290,308 (126) % Foreign Exchange Loss (217,317) (44,062) (173,255) 393 % Utility Improvement Refund — 208,271 (208,271) (100) % Total Other Income, Net 433,337 2,152,462 (1,719,125) (80) % Net Loss $ (73,538,157) $ (50,149,077) $ (23,389,080) 47 % 37 Table of Contents Sales.
Exposure to inventory valuation risks is managed by maintaining safety stocks, minimum purchase lots, managing 31 Table of Contents product and end-of-life issues brought on by aging components or new product introductions, and by utilizing certain inventory minimization strategies such as vendor-managed inventories.
Exposure to inventory valuation risks is managed by maintaining safety stocks, minimum purchase lots, managing product and end-of-life issues brought on by aging components or new product introductions, and by utilizing certain inventory minimization strategies such as vendor-managed inventories.
In addition to its normal Reserve for Obsolescence provision, the Company reserved as of December 31, 2023 additional provisions for expected surplus component parts and obsolescence in excess of its currently planned existing product builds in 2024 and into 2025 on most of its existing smart glass product models in anticipation of the planned introduction of newer models, which would logically replace the existing models when introduced.
In addition to its normal Reserve for Obsolescence provision, the Company reserved as of December 31, 2025 additional provisions for expected surplus component parts and obsolescence in excess of its currently planned existing product builds in 2026 on most of its existing smart glass product models in anticipation of the planned introduction of newer models, which would logically replace the existing models when introduced.
Our wearable display devices are worn like eyeglasses or attach to a head worn mount. These devices typically include cameras, sensors, and a computer that enable the user to view, record and interact with video and digital content, such as computer data, the Internet, social media or entertainment applications.
Our wearable display devices are 27 Table of Contents worn like eyeglasses or attach to a head worn mount. These devices typically include cameras, sensors, and a computer that enable the user to view, record and interact with video and digital content, such as computer data, the Internet, social media or entertainment applications.
Sales of engineering services for the year ended December 31, 2024, was $1,267,354, as compared to $1,368,787 in 2023, a decrease of 7%. Cost of Sales and Gross Profit (Loss).
Sales of engineering services for the year ended December 31, 2024, were $1,267,354, as compared to $1,368,787 in 2023, a decrease of 7%. Cost of Sales and Gross Loss.
The Company had a related equity interest in Atomistic, a private French company, and determined that at this time, the Company is unable to reasonably estimate a value to its future value and therefore recorded a full impairment of its investment in Atomistic resulting in a write-down charge of $5,784,125 for the period ended June 30, 2024. Other Income (Expense), Net .
The Company had a related equity interest in Atomistic, a private French company, and determined that the Company was unable to reasonably estimate its future value and therefore recorded a full impairment of its investment in Atomistic resulting in a write-down charge of $5,784,125 for the period ended June 30, 2024. Other Income (Expense), Net .
The critical accounting policies, judgments and estimates that we believe have the most significant effect on our financial statements are: ● Valuation of inventories; ● Going Concern; ● Variable interest entities; ● Investments in equity securities; ● Carrying value of long-lived assets, goodwill and other intangible assets; ● Software development costs; ● Revenue recognition; ● Product warranty; ● Stock-based compensation; and ● Income taxes.
The critical accounting policies, judgments and estimates that we believe have the most significant effect on our financial statements are: ● Valuation of inventories; ● Going concern; ● Evaluation of Liabilities to Equity and Derivatives ● Variable interest entities; ● Investments in equity securities; ● Carrying value of long-lived assets, goodwill and other intangible assets; ● Software development costs; 28 Table of Contents ● Revenue recognition; ● Product warranty; ● Stock-based compensation; and ● Income taxes.
In the event that it should be determined that all or part of a deferred tax asset in the future is more likely than not to be realized, an adjustment (reduction) of the valuation allowance would increase income to be recognized in the period such determination was made.
In the event that we determine that all or part of a deferred tax asset in the future is more likely than not to be realized, an adjustment (reduction) of the valuation allowance would increase income to be recognized in the period such determination was made.
The Company’s management intends to continue to take actions necessary to continue as a going concern, as discussed herein.
Management intends to take actions necessary to continue as a going concern, as discussed herein.
The disposal value of the excess components that could not be used in future models is unknown, so a 100% obsolescence provision has been accrued. During the year ended December 31, 2024, the Company wrote-off gross inventory of $4,167,917 and disposed of $1,998,893 of inventory that was fully provisioned for in the previous year.
The disposal value of the excess components that could not be used in future models was unknown, so a 100% obsolescence provision was accrued. During the year ended December 31, 2024, the Company recorded an obsolescence provision for gross inventory of $4,167,917 and disposed of $1,998,893 of inventory that was fully provisioned for in the previous year.
Stock-Based Compensation Expense Our Board of Directors approves grants of stock awards and options to employees to purchase our common stock. Stock-based compensation expense is recorded based upon the estimated fair value of the stock option or stock award at the date of grant.
Stock-Based Compensation Expense Our Board of Directors approves grants of stock awards, including restricted stock units (“RSUs) and performance stock units (“PSUs”) and options to employees and independent directors to purchase our common stock. Stock-based compensation expense is recorded based upon the estimated fair value of the stock option or stock award at the date of grant.
Product sales represent the majority of the Company’s revenue. The Company recognizes revenue from these product sales as performance obligations are satisfied and transfer of control to the customer has occurred, typically upon physical shipment. Revenue is recognized in the amount that the Company expects to receive in exchange from the sale of our products.
The Company recognizes revenue from these product sales as performance obligations are satisfied and transfer of control to the customer has occurred. Revenue is recognized in the amount that the Company expects to receive in exchange for the sale of our products.
The write-off to our obsolescence provision for finished goods and components totaled $4,167,917, $4,358,062, and $290,405 for the years ended December 31, 2024, 2023, and 2022, respectively. These additional obsolescence provisions are included in Cost of Sales in the Consolidated Statements of Operations.
The increase to our obsolescence provision for finished goods and components totaled $503,400, $4,167,917, and $4,358,062 for the years ended December 31, 2025, 2024, and 2023, respectively. These additional obsolescence provisions are included in Cost of Sales in the Consolidated Statements of Operations.
As a result of management’s plan above, our current amount of cash on hand, and our historical ability to raise capital, management has concluded that substantial doubt of our ability to continue as a going concern has been alleviated. Contractual Obligations The following is a summary of our contractual payment obligations as of December 31, 2024: Less than More than Contractual Obligations Total 1 Year 1-3 Years 3-5 Years 5 Years Operating Lease Obligations $ 511,980 $ 511,980 $ — — — Open Purchase Obligations 1,061,429 1,061,429 — — —
As a result of management’s plan above, our current amount of cash on hand, and our historical ability to raise capital, management has concluded that substantial doubt of our ability to continue as a going concern has been alleviated. Contractual Obligations The following is a summary of our contractual payment obligations as of December 31, 2025: Less than More than Contractual Obligations Total 1 Year 1-3 Years 3-5 Years 5 Years Operating Lease Obligations $ 1,087,103 $ 567,184 $ 519,919 — — Open Purchase Obligations 3,278,002 3,278,002 — — —
Our current liabilities are comprised principally of accounts payable, accrued expenses, and operating lease right-of-use liabilities. Summary of Cash Flow: The following table summarizes our select cash flows for the years ended: December 31, December 31, December 31, 2024 2023 2022 Net Cash Provided by (used in) Operating Activities (23,739,372) (26,277,824) (24,521,082) Investing Activities (2,919,949) (19,280,966) (21,170,816) Financing Activities 18,290,235 (449,561) (1,948,032) During the year ended December 31, 2024 we used $23,739,372 of cash for operating activities.
Our current liabilities are comprised principally of accounts payable, accrued expenses, and operating lease right-of-use liabilities. 40 Table of Contents Summary of Cash Flow: The following table summarizes our select cash flows for the years ended: December 31, December 31, December 31, 2025 2024 2023 Net Cash Provided by (used in) Operating Activities (18,789,272) (23,739,372) (26,277,824) Investing Activities (2,618,270) (2,919,949) (19,280,966) Financing Activities 24,371,250 18,290,235 (449,561) During the year ended December 31, 2025 we used $18,789,272 of cash for operating activities.
Unregistered Sales of Equity Securities and Use of Proceeds Sales of Unregistered Securities - none 29 Table of Contents Purchase of Equity Securities - none Equity Compensation Plan Information The following table provides information about our equity compensation plan as of December 31, 2024. Number of Weighted Securities to Average be Issued Exercise Price Number of Upon Exercise of Securities of Outstanding Outstanding Remaining Options, Options, Available for Warrants and Warrants and Future Issuance Plan Category Rights Rights (1) Equity compensation plans approved by security holders 10,367,990 $ 12.41 1,031,737 Equity compensation plans not approved by security holders — — — Total 10,367,990 $ 12.41 1,031,737 (1) The amount appearing under “Number of securities remaining available for future issuance” includes shares available under the Company’s 2023 Equity Incentive Plan (the “2023 Plan”).
Unregistered Sales of Equity Securities and Use of Proceeds Sales of Unregistered Securities - none Purchase of Equity Securities - none Equity Compensation Plan Information The following table provides information about our equity compensation plan as of December 31, 2025. Number of Weighted Securities to Average be Issued Exercise Price Number of Upon Exercise of Securities of Outstanding Outstanding Remaining Options, Options, Available for Warrants and Warrants and Future Issuance Plan Category Rights Rights (1) Equity compensation plans approved by security holders 6,078,999 $ 3.37 2,795,108 Equity compensation plans not approved by security holders — — — Total 6,078,999 $ 3.37 2,795,108 (1) The amount appearing under “Number of securities remaining available for future issuance” includes shares available under the Company’s 2023 Equity Incentive Plan (the “2023 Plan”).
The unamortized software development costs remaining were valued (net of accumulated amortization) at $194,445 as of December 31, 2024. Management believes that this value is recoverable. 33 Table of Contents Revenue Recognition The Company adopted the guidance on Revenue from Contracts with Customers under FASB ASC Topic 606, Revenue from Contracts with Customers , as of January 1, 2018.
The unamortized software development costs remaining were valued (net of accumulated amortization) at $27,778 as of December 31, 2025. Management believes that this value is recoverable. Revenue Recognition The Company adopted the guidance under FASB ASC Topic 606, Revenue from Contracts with Customers , as of January 1, 2018. Product sales represent the majority of the Company’s revenue.
With respect to our Smart Glasses and AI/AR products, we are focused on the enterprise, defense, industrial, medical and commercial markets.
With respect to our Smart Glasses and AI/AR products, we are focused on the enterprise, defense, medical, security, and select consumer applications.
The Company incurred net losses for the year ended December 31, 2024 of $73,538,157; $50,149,077 for the year ended December 31, 2023; and $40,763,573 for the year ended December 31, 2022.
The Company incurred net losses for the year ended December 31, 2025 of $32,273,128; $73,538,157 for the year ended December 31, 2024; and $50,149,077 for the year ended December 31, 2023.
The Company incurred net losses for the year ended December 31, 2024 of $73,538,157; $50,149,077 for the year ended December 31, 2023; and $40,763,573 for the year ended December 31, 2022.
The Company incurred net losses for the year ended December 31, 2025 of $32,273,128; $73,538,157 for the year ended December 31, 2024; and $50,149,077 for the year ended December 31, 2023.
These consolidated financial statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue as a going concern.
This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue 29 Table of Contents as a going concern.
Future warranty costs are estimated based on historical performance rates and related costs to repair given products. The accounting estimate related to product warranty is considered a “critical accounting estimate” because judgment is exercised in determining future estimated warranty costs. Should actual performance rates or repair costs differ from estimates, revision to the estimated warranty liability would be required.
Future warranty costs are estimated 31 Table of Contents based on historical performance rates and related costs to repair given products. The accounting estimate related to product warranty is considered a “critical accounting estimate” because judgment is exercised in determining future estimated warranty costs.
The Company had net cash outflows from operations of $23,739,372 for the year ended December 31, 2024; $26,277,824 for the year ended December 31, 2023; and $24,521,082 for the year ended December 31, 2022. As of December 31, 2024, the Company had an accumulated deficit of $367,522,950.
The Company had net cash outflows from operations of $18,789,272 for the year ended December 31, 2025; $23,739,372 for the year ended December 31, 2024; and $26,277,824 for the year ended December 31, 2023. As of December 31, 2025, the Company had an accumulated deficit of $399,858,410.
As of December 31, 2024, the Company had an accumulated deficit of $367,522,950. The ongoing losses and accumulated deficit initially raise substantial doubt about the Company’s ability to continue as a going concern.
The ongoing losses and accumulated deficit initially raise substantial doubt about the Company’s ability to continue as a going concern.
Smart glasses revenue was the primary driver of this increase as unit sales of our M400 product increased. Sales of engineering services for the year ended December 31, 2023, were $1,368,787, as compared to $1,330,119 in the same period of 2022, an increase of 3%. Cost of Sales and Gross Profit (Loss).
Increased smart glasses revenue was the primary driver of this increase as unit sales of our M400 product increased compared to the previous year. Sales of engineering services and OEM products for the year ended December 31, 2025, were $1,603,979, as compared to $1,267,354 in 2024, an increase of 27%. Cost of Sales and Gross Loss.
We continually evaluate our estimates used in the preparation of our consolidated financial statements, including those related to revenue recognition, bad debt, inventories, warranty reserves, product warranty, carrying value of long-lived assets, derivatives, valuation of stock compensation awards, and income taxes.
We continually evaluate our estimates used in the preparation of our consolidated financial statements, including those related to valuation of inventories, going concern, variable interest entities, investments in equity securities, carrying value of long-lived assets, goodwill and other intangible assets, software development costs, revenue recognition, product warranty, valuation of stock-based compensation, and income taxes.
Provision for Income Taxes . There were no provisions for income taxes in 2023 or 2022. Liquidity and Capital Resources Capital Resources: As of December 31, 2024, we had cash and cash equivalents of $18,186,506, a decrease of $8,369,086 from $26,555,592 as of December 31, 2023.
Provision for Income Taxes . There were no provisions for income taxes in 2024 or 2023. Liquidity and Capital Resources Capital Resources: As of December 31, 2025, we had cash and cash equivalents of $21,150,213, an increase of $2,963,707 from $18,186,506 as of December 31, 2024.
The Company had net cash outflows from operations of $23,739,372 for the year ended December 31, 2024; $26,277,824 for the year ended December 31, 2023; and $24,521,082 for the year ended December 31, 2022.
The Company had net cash outflows from operations of $18,789,272 for the year ended December 31, 2025; $23,739,372 for the year ended December 31, 2024; and $26,277,824 for the year ended December 31, 2023. As of December 31, 2025, the Company had an accumulated deficit of $399,858,410.
As a result, the Company has no further contractual requirements to pay further licensing development fees to Atomistic. Our cash requirements related to funding operating losses depend upon numerous factors, including new product development activities, our ability to commercialize our products, our products’ timely market acceptance, selling prices and gross margins, and other factors.
The Company’s cash requirements going forward are primarily for funding operating losses, research and development, working capital, and capital expenditures. Our cash requirements related to funding operating losses depend upon numerous factors, including new product development activities, research and development costs, our ability to commercialize our products, our products’ timely market acceptance, selling prices and gross margins, and other factors.
The fair value of our common stock on the date of each option grant is determined based on the most recent quoted sales price on our primary trading stock exchange, currently the NASDAQ Capital Market. For stock options awards under the Company's LTIP (Long-term Incentive Plan), options vest upon the achievement of certain equity market conditions and performance-based milestones.
The fair value of our common stock, including PSUs and RSUs, on the date of each equity grant is determined based on the most recent quoted sales price on our primary trading stock exchange, currently the NASDAQ Capital Market.
The Company has historically raised capital through the sale of equity securities. The Company has entered into a sales agreement with an investment bank for the issuance and sale of up to $50,000,000 of our common stock that may be issued and sold from time to time in an “at the market” (ATM) offering.
The Company filed a Registration Statement on Form S-3 that became effective in May 2024, which includes a sales agreement prospectus for the issuance and sale of up to $50,000,000 of our common stock that may be issued and sold from time to time under a sales agreement with an investment bank in an “at the market” offering.
For the years ended December 31, 2024, 2023, and 2022, we recorded a loss on fixed asset disposal of $27,654, nil, and $35,350, respectively, upon the retirement of certain tooling and manufacturing equipment assets no longer in use. We perform an evaluation of our patents and trademark assets when events or circumstances indicate their carrying amounts may be unrecoverable.
For the years 30 Table of Contents ended December 31, 2025, 2024, and 2023, we recorded a loss on fixed asset disposal of $106,898, $27,654, and nil, respectively, upon the retirement of certain tooling and manufacturing equipment assets no longer in use.
For the years ended December 31, 2024, 2023, and 2022, there was an impairment charge of nil, $41,869, and $97,675, respectively. The carrying value of the remaining intellectual property, such as patents and trademarks, was valued (net of accumulated amortization) at $2,998,760 as of December 31, 2024, because management believes that this value is recoverable.
The carrying value of the remaining intellectual property, such as patents and trademarks, was valued (net of accumulated amortization) at $3,359,066 as of December 31, 2025, because management believes that this value is recoverable.
We believe our technology, intellectual property portfolio and position in the marketplace give us a leadership position in AI/AR and Smart Glasses products, waveguide optics, microLEDs and display engine technology. 30 Table of Contents Critical Accounting Policies and Significant Developments and Estimates The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements and related notes appearing elsewhere in this annual report.
Critical Accounting Policies and Significant Developments and Estimates The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements and related notes appearing elsewhere in this annual report.
Net changes in working capital items were $1,171,047 for the year ended December 31, 2024, with the largest factors resulting from a $2,503,100 decrease in trade accounts payables and accrued expenses; a $941,149 decrease in trade accounts and other receivables; and a $271,399 decrease in other prepaid expenses.
Net changes in working capital items were $3,993,328 for the year ended December 31, 2025, with the largest factors resulting from a $2,237,067 decrease in inventory and vendor prepayments; a $2,028,448 increase in trade accounts payables and accrued expenses; and a $257,699 increase in trade accounts and other receivables.
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Holders of Record As of March 13, 2025, there were 89 holders of record of our common stock.
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Market Information Our common stock is listed on the Nasdaq Capital Market under the symbol “VUZI.” 26 Table of Contents Holders of Record As of March 12, 2026, there were 50 holders of record of our common stock.
As of December 31, 2024, we had current assets of $26,722,490 as compared to current liabilities of $2,112,273, which resulted in a positive working capital position of $24,610,217. As of December 31, 2023, we had a working capital position of $36,284,259.
As of December 31, 2025, we had current assets of $27,195,727 compared to current liabilities of $4,888,202, which resulted in a positive working capital position of $22,307,525. As of December 31, 2024, we had a working capital position of $24,610,217.
The disposal value of the excess components that could not be used in future models is unknown, so a 100% obsolescence provision has been accrued. The total reserve write-down recorded at December 31, 2023 was $2,700,000 and the Company increased its standard reserve by $1,658,000.
The disposal value of the excess components that could not be used in future models is unknown, so a 100% obsolescence provision has been accrued.
For the year ended December 31, 2023, we used a total of $26,277,824 in cash for operating activities.
For the year ended December 31, 2024, we used $23,739,372 in cash for operating activities.
For the year ended December 31, 2023, we used a total of $19,280,966 in cash for investing activities.
For the year ended December 31, 2024, we used $2,919,949 in cash for investing activities.
It presumes that a Company will continue normal business operations into the future. 32 Table of Contents Variable Interest Entities We determine at the inception of each arrangement whether an entity in which we have made an investment or in which we have other variable interests is considered a variable interest entity (VIE).
Changes in these classifications or valuations could materially affect the Company’s financial position and results of operations. Variable Interest Entities We determine at the inception of each arrangement whether an entity in which we have made an investment or in which we have other variable interests is considered a variable interest entity (VIE).
Management’s plans to alleviate the conditions that raise substantial doubt include operational improvements being implemented and the curtailment of certain development programs, both of which the Company expects will preserve cash. The Financial Accounting Standards Board (FASB) issued Accounting Standards Update No.
Management’s plans to alleviate the conditions that raise substantial doubt include operational improvements being implemented and the curtailment of certain development programs, both of which the Company expects will preserve cash. Evaluation of Liabilities, Equity and Derivatives The Company evaluates whether financial instruments issued by the Company should be classified as liabilities, mezzanine equity, or permanent equity and whether such instruments contain features that meet the definition of a derivative.
There was an increase in total sales for the year ended December 31, 2023, from those achieved in 2022 of $293,257, or 2%.
There was an increase in total sales for the year ended December 31, 2025, compared to 2024 of $526,055, or 9%.
For equity securities without a readily determinable fair value, the investment is recorded at cost, less any impairment, plus or minus adjustments related to observable transactions for the same or similar securities, with unrealized gains and losses included in earnings. Carrying Value of Long-Lived Assets If facts and circumstances indicate that a long-lived asset, including a products’ mold tooling and equipment, may be impaired, the carrying value is reviewed in accordance with FASB ASC Topic 360-10 Accounting for the Impairment or Disposal of Long-Lived Assets .
For equity securities without a readily determinable fair value, the investment is recorded at cost, less any impairment, plus or minus adjustments related to observable transactions for the same or similar securities, with unrealized gains and losses included in earnings. As of December 31, 2025 and 2024, we had $300,000 and $650,000 of investments in equity securities.
Selling and marketing expenses consist of trade show costs, advertising, sales samples, travel costs, sales staff compensation costs including stock-based compensation expense, consulting fees, public relations agency fees, website costs and sales commissions paid to full-time staff and outside consultants. Year Ended % of Year Ended % of Dollar % Increase December 31, 2023 Total Sales December 31, 2022 Total Sales Change (Decrease) Selling and Marketing Expenses $ 11,632,032 96 % $ 7,156,266 60 % $ 4,475,766 63 % Related Stock-based Compensation (non-cash) 1,079,768 9 % 922,272 8 % 157,496 17 % Total Selling and Marketing $ 12,711,800 105 % $ 8,078,538 68 % $ 4,633,262 57 % Selling and marketing expenses for the year ended December 31, 2023, increased by $4,633,262 or 57%, compared to the comparable period in 2022.
Selling and marketing expenses consist of trade show costs, advertising, sales samples, travel costs, sales staff compensation costs including stock-based compensation expense, consulting fees, public relations agency fees, website costs and sales commissions paid to full-time staff and outside consultants. Year Ended % of Year Ended % of Dollar % Increase December 31, 2025 Total Sales December 31, 2024 Total Sales Change (Decrease) Selling and Marketing Expenses $ 4,690,931 75 % $ 6,953,169 121 % $ (2,262,238) (33) % Related Stock-based Compensation (non-cash) 787,665 12 % 1,238,258 21 % (450,593) (36) % Total Selling and Marketing $ 5,478,596 87 % $ 8,191,427 142 % $ (2,712,831) (33) % Selling and marketing expenses for the year ended December 31, 2025 decreased by $2,712,831, or 33% compared to 2024.
Depreciation and Amortization. Depreciation and amortization expense, not included in cost of sales, for the year ended December 31, 2023, was $3,844,428, compared to $1,788,584 in the comparable period in 2022, an increase of $2,055,844.
Depreciation and Amortization. Depreciation and amortization expense, not included in cost of sales or research and development, for the year ended December 31, 2025 was $1,602,632, compared to $2,994,643 in 2024 or a decrease of $1,392,011.
The increase in this expense is primarily due to the amortization of our technology license related to the Atomistic Agreements, which began on May 12, 2022. Other Income (Expense), Net . Total other income was $2,152,462 for the year ended December 31, 2023, as compared to $1,468,698 in the same period in 2022, an increase of $683,764.
This decrease was primarily due to a significant decrease in amortization expense related to our Atomistic technology license, which was written off as of June 30, 2024. Other Income (Expense), Net . Total other income was $234,766 for the year ended December 31, 2025, compared to other income of $433,337 in 2024, a decrease of $198,571.
Software development expenses to determine technical feasibility before final development and ongoing maintenance are not capitalized and are included in research and development expenses. Year Ended % of Year Ended % of Dollar % Increase December 31, 2023 Total Sales December 31, 2022 Total Sales Change (Decrease) Research and Development Expenses $ 10,611,176 87 % $ 10,841,011 92 % $ (229,835) (2) % Related Stock-based Compensation (non-cash) 1,728,358 14 % 1,835,677 16 % (107,319) (6) % Total Research and Development $ 12,339,534 102 % $ 12,676,688 107 % $ (337,154) (3) % Research and development expenses for the year ended December 31, 2023, decreased by $337,154, or 3%, compared to the comparable period in 2022.
Software development expenses to determine technical feasibility before final development and ongoing maintenance are not capitalized and are included in research and development expenses. Year Ended % of Year Ended % of Dollar % Increase December 31, 2025 Total Sales December 31, 2024 Total Sales Change (Decrease) Research and Development Expenses $ 11,774,608 187 % $ 7,840,491 136 % $ 3,934,117 50 % Related Stock-based Compensation (non-cash) 850,948 14 % 1,785,961 31 % (935,013) (52) % Total Research and Development Costs $ 12,625,556 201 % $ 9,626,452 167 % $ 2,999,104 31 % Research and development expenses for the year ended December 31, 2025 increased by $2,999,104, or 31% compared to 2024.
During the year ended December 31, 2024, we used $2,919,949 of cash for investing activities, which included: $1,358,991 in manufacturing equipment and tooling for our new waveguide manufacturing facility; $1,000,000 final payment made towards our technology license fee commitment with Atomistic; and $560,958 in patent and trademark expenditures.
During the year ended December 31, 2025, we used $2,618,270 of cash for investing activities, which included: $2,013,454 in manufacturing equipment and tooling primarily for our new waveguide manufacturing facility; $554,816 in patent and trademark expenditures, and $50,000 of additional investment in a private corporation (see Note 8 in the Consolidated Financial Statements for further details).
General and administrative expenses include professional fees, investor relations (IR) costs, salaries and related stock compensation, travel costs, office and rental costs. Year Ended % of Year Ended % of Dollar % Increase December 31, 2023 Total Sales December 31, 2022 Total Sales Change (Decrease) General and Administrative Expenses $ 8,933,458 74 % $ 8,502,412 72 % $ 431,046 5 % Related Stock-based Compensation (non-cash) 9,658,727 80 % 12,536,150 106 % (2,877,423) (23) % Total General and Administrative $ 18,592,185 153 % $ 21,038,562 178 % $ (2,446,377) (12) % General and administrative expenses for the year ended December 31, 2023 decreased by $2,446,377, or 12% compared to the comparable period in 2022.
General and administrative expenses include professional fees, investor relations (IR) costs, salaries and related stock compensation, travel costs, office and rental costs. Year Ended % of Year Ended % of Dollar % Increase December 31, 2025 Total Sales December 31, 2024 Total Sales Change (Decrease) General and Administrative Expenses $ 8,205,903 131 % $ 8,933,952 155 % $ (728,049) (8) % Related Stock-based Compensation (non-cash) 3,425,915 55 % 8,296,341 144 % (4,870,426) (59) % Total General and Administrative $ 11,631,818 185 % $ 17,230,293 299 % $ (5,598,475) (32) % General and administrative expenses for the year ended December 31, 2025, decreased by $5,598,475, or 32%, compared to 2024.
The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business.
GAAP financial reporting and presumes that the Company will continue normal business operations into the foreseeable future, unless such conditions or events raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
This overall increase was primarily the result of an increase of $823,647 in investment income resulting from the rise in interest rates earned on the Company’s excess cash period-over-period; and decrease of $136,527 in foreign exchange losses; partially offset by a $258,434 reduction in government and utility incentives, primarily related to the employee retention refunds received in 2022.
The overall decrease in other income was primarily the result of a $400,000 impairment charge on equity investments; a decrease of $36,281 in foreign tax refunds; partially offset by a decrease of $156,753 in foreign exchange losses and a $80,957 increase in investment income earned on excess cash on hand. Provision for Income Taxes .